Phendimetrazine
Phendimetrazine is a weight loss medication.It is chemically related to amphetamines. It is clinically in form of Phendimetrazine tartarate. Phendimetrazine tartarate is a central stimulant and indirect acting sympathomimetic with actions similar to those of dexamfetamine.
Primary Characteristics
Phendimetrazine is also known as phendimetrazine acid tartarate, Phendimetrazine Tartarate.
It belongs to amphetamines.
Solubility in Water: soluble · Solubility in Alcohol: sparingly soluble · Non-proprietary name: Phendimetrazine..

Pharmacokinetics
Elimination: renal excretion is through urine partly unchanged.
Advertisement
Indications
Phendimetrazine is primarily indicated in conditions like Anorectal infections, Obesity.
Phendimetrazine is also indicated for secondary conditions like Fatigue, Narcolepsy.
Contraindications
Phendimetrazine is contraindicated in conditions like Hypersensitivity.
Dosage
Phendimetrazine's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 35 mg | 35 mg | Every 12h | oral | |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Phendimetrazine in overdosage may give rise to further complications which include Allergic reactions , Confusion , Irregular heart beat, Cardiac arrhythmias.
The signs and symptoms that are produced after acute overdosage of Phendimetrazine are Seizures, Dry mouth, Confusion , Hallucinations , Tremor, Restlessness , Aggression, Convulsions , Coma, Mydriasis, Chest pain, Hyperflexia .
Phendimetrazine is known to cause more or less tolerable side effects which are usually transient. These include Blurred vision, Depression, Dizziness, Fatigue, Insomnia, Nausea and vomiting, Nervousness, Restlessness.
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.17.10 — Antiobesity preparations
- 2.21.4.3 — Sympathomimetics